指南与共识冠心病心力衰竭与心肌病心律失常

肥胖与心血管疾病:ESC临床共识声明

Obesity and cardiovascular disease: an ESC clinical consensus statement.
指南 / 共识 · Eur Heart J · 2024-01-01

该ESC临床共识声明指出,过去四十年全球肥胖患病率翻倍以上,现影响超过十亿人,肥胖是与多种慢性疾病存在因果关联的高危状态,且已被认定为一种疾病本身,可损害生活质量并缩短预期寿命。肥胖相关超额死亡中三分之二可归因于心血管疾病。声明讨论肥胖的流行病学与病因、肥胖与心血管危险因素及心脏疾病的相互作用、心脏病合并肥胖患者的临床管理,以及减重策略(生活方式、介入操作、抗肥胖药物)对心脏代谢风险与心脏结局的影响。

要点

  • 肥胖已被认定为一种疾病,与动脉粥样硬化性疾病、心衰、血栓栓塞性疾病、心律失常及心源性猝死相关。
  • 肥胖相关超额死亡中三分之二归因于心血管疾病。
  • 与其他可干预心血管危险因素相比,肥胖仍被低估且管理欠佳,需在心血管一级和二级预防中落实循证防治。

核心结论

  • 肥胖是与多种慢性疾病存在因果关联的高危状态,并已被认定为一种疾病,可导致生活质量受损和预期寿命缩短。
  • 肥胖相关超额死亡中三分之二可归因于心血管疾病。
  • 与其他可干预心血管危险因素相比,肥胖被低估且处理欠佳,需加强预防与最佳管理。

研究设计与样本

  • 欧洲心脏病学会(ESC)发布的临床共识声明。
  • 文件讨论肥胖的流行病学与病因、肥胖与心血管危险因素及心脏疾病的相互作用、心脏病合并肥胖患者的临床管理及减重策略。
  • 减重策略涵盖生活方式改变、介入操作和抗肥胖药物,并重点关注其对心脏代谢风险与心脏结局的影响。

主要发现

  • 过去四十年全球肥胖患病率翻倍以上,目前影响超过十亿人。
  • 肥胖与动脉粥样硬化性疾病、心力衰竭、血栓栓塞性疾病、心律失常和心源性猝死等多种心血管疾病表现相关。
  • 肥胖相关超额死亡中三分之二可归因于心血管疾病。
  • 肥胖与其他可干预心血管危险因素相比被低估且管理欠佳。

临床怎么用

  • 从儿童早期到整个成年期,采取人群层面与个体化相结合的方法预防超重和维持健康体重。
  • 对已确诊肥胖者实施综合减重干预,包括生活方式改变、介入操作和抗肥胖药物。
  • 在心血管一级和二级预防框架内落实循证实践,加强对肥胖的识别与最佳管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The global prevalence of obesity has more than doubled over the past four decades, currently affecting more than a billion individuals. Beyond its recognition as a high-risk condition that is causally linked to many chronic illnesses, obesity has been declared a disease per se that results in impaired quality of life and reduced life expectancy. Notably, two-thirds of obesity-related excess mortality is attributable to cardiovascular disease. Despite the increasingly appreciated link between obesity and a broad range of cardiovascular disease manifestations including atherosclerotic disease, heart failure, thromboembolic disease, arrhythmias, and sudden cardiac death, obesity has been underrecognized and sub-optimally addressed compared with other modifiable cardiovascular risk factors. In the view of major repercussions of the obesity epidemic on public health, attention has focused on population-based and personalized approaches to prevent excess weight gain and maintain a healthy body weight from early childhood and throughout adult life, as well as on comprehensive weight loss interventions for persons with established obesity. This clinical consensus statement by the European Society of Cardiology discusses current evidence on the epidemiology and aetiology of obesity; the interplay between obesity, cardiovascular risk factors and cardiac conditions; the clinical management of patients with cardiac disease and obesity; and weight loss strategies including lifestyle changes, interventional procedures, and anti-obesity medications with particular focus on their impact on cardiometabolic risk and cardiac outcomes. The document aims to raise awareness on obesity as a major risk factor and provide guidance for implementing evidence-based practices for its prevention and optimal management within the context of primary and secondary cardiovascular disease prevention.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Koskinas, Van Craenenbroeck, Antoniades, et al. Obesity and cardiovascular disease: an ESC clinical consensus statement. Eur Heart J. 2024. PMID: 39210706. doi:10.1093/eurheartj/ehae508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。